Date of dispatch of this notice: 29/11/2017
Expire date: 10/01/2018
External Reference: 2017-986227
TED Reference: 2017/S 230-479093
Contract notice
Information
Published
Contract notice
Cached Version
Contract notice
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
St James's Hospital
N/A
James Street
Dublin
Dublin 8
IE
Contact person:
David Gunning
Telephone:
+353 14284707
E-mail:
DGunning@STJAMES.IE
NUTS code:
IE -
IRELAND
Main address:
http://www.stjames.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/395
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=122150&B=ETENDERS_SIMPLEAdditional information can be obtained from
the abovementioned address:
Tenders or requests to participate must be submitted
electronically via:
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=122150&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Provision of Fluorescent in situ Hybridisation (FISH) Services
II.1.2)
Main CPV code
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.1.3)
Type of contract
Supplies
II.1.4)
Short description
The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James’s Hospital has provided a hospital and national service since the 2010. The service is staffed by two medical scientists. Currently the service offers the following assays for diagnostics and predictive testing:
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
II.1.5)
Estimated total value
Value excluding VAT: 850000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2)
Description
II.2.2)
Additional CPV code(s)
33000000
-
Medical equipments, pharmaceuticals and personal care products
33100000
-
Medical equipments
33124110
-
Diagnostic systems
33141625
-
Diagnostic kits
33694000
-
Diagnostic agents
38434540
-
Biomedical equipment
51430000
-
Installation services of laboratory equipment
71900000
-
Laboratory services
85121200
-
Medical specialist services
85145000
-
Services provided by medical laboratories
II.2.3)
Place of performance
NUTS code:
IE -
IRELAND
Main site or place of performance:
St James's Hospital
II.2.4)
Description of the procurement
The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James’s Hospital has provided a hospital and national service since the 2010. The service is staffed by two medical scientists. Currently the service offers the following assays for diagnostics and predictive testing:
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
• Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
• Gene rearrangement /translocations found in Lymphomas
• Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
• DUSP22, TP63 rearrangements
• 11q aberration.
Possible development of Myeloma FISH service.
II.2.5)
Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)
Estimated value
Value excluding VAT: 850000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
60
This contract is subject to renewal:
no
II.2.9)
Information about the limits on the number of candidates to be invited
Envisaged minimum number:
3
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
Section III: Legal, economic, financial and technical information
III.1)
Conditions for participation
III.1.2)
Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3)
Technical and professional ability
Selection criteria as stated in the procurement documents
III.2)
Conditions related to the contract
III.2.3)
Information about staff responsible for the performance of the contract
Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Competitive dialogue
IV.1.4)
Information about reduction of the number of solutions or tenders during negotiation or dialogue
Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)
Administrative information
IV.2.2)
Time limit for receipt of tenders or requests to participate
Date:
1/10/2018
Local time:
12:00
IV.2.3)
Estimated date of dispatch of invitations to tender or to participate to selected candidates
Date: 3/2/2018
IV.2.4)
Languages in which tenders or requests to participate may be submitted
English
Section VI: Complementary information
VI.1)
Information about recurrence
This is a recurrent procurement:
no
VI.2)
Information about electronic workflows
Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4)
Procedures for review
VI.4.1)
Review body
Hig Court
Dublin
Dublin
IE